Signaling Pathways Involved in Cognitive Enhancement

Cognitive Enhancement: Pharmacologic, Environmental and Genetic Factors

Volumn , Issue , 2015, Pages 11-42

  Nelson, Thomas J ^a   Sun, Miao Kun ^a   Alkon, Daniel L ^b  

^a Blanchette Rockefeller Neurosciences Institute   (United States)

^b Blanchette Rockefeller Neurosciences Institute   (United States)

Author keywords

Apolipoprotein E; Brain derived neurotrophic factor (BDNF); Bryostatin; Dendritic spine; Ephrin; Insulin; Learning; Memory; Neurosteroids; Protein kinase C; Rho GTPase; Stress

Indexed keywords

EID: 84944577502     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-417042-1.00002-4     Document Type: Chapter

References (218)

1. Adasme T., Haeger P., Paula-Lima A.C., Espinoza I., Casas-Alarcón M.M., Carrasco M.A. Involvement of ryanodine receptors in neurotrophin-induced hippocampal synaptic plasticity and spatial memory formation. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:3029-3034.
2. Agosta F., Vossel K.A., Miller B.L., Migliaccio R., Bonasera S.J., Filippi M., et al. Apolipoprotein E ε4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:2018-2022.
3. Alkon D.L., Lederhendler I., Shoukimas J.J. Primary changes of membrane currents during retention of associative learning. Science 1982, 215:693-695.
4. Alkon D.L., Rasmussen H. A spatial-temporal model of cell activation. Science 1988, 239:998-1005.
5. + channels by cytoplasmic and membrane-associated C-kinase. J. Neurochem. 1988, 51:903-917.
6. + channel cascade. Trends Neurosci. 1998, 21:529-537.
7. Alkon D.L., Epstein H., Kuzirian A., Bennett M.C., Nelson T.J. Protein synthesis required for long-term memory is induced by PKC activation on days before associative learning. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:16432-16437.
8. Ambrogini P., Lattanzi D., Ciuffoli S., Betti M., Fanelli M., Cuppini R. Physical exercise and environment exploration affect synaptogenesis in adult-generated neurons in the rat dentate gyrus: possible role of BDNF. Brain Res 2013, 1534:1-12.
9. Ammar M.R., Humeau Y., Hanauer A., Nieswandt B., Bader M.F., Vitale N. The Coffin-Lowry syndrome-associated protein RSK2 regulates neurite outgrowth through phosphorylation of phospholipase D1 (PLD1) and synthesis of phosphatidic acid. J. Neurosci. 2013, 33:19470-19479.
10. Andero R., Heldt S.A., Ye K., Liu X., Armario A., Ressler K.J. Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning. Am. J. Psychiatry 2011, 168:163-172.
11. Augustin I., Korte S., Rickmann M., Kretzschmar H.A., Südhof T.C., Herms J.W., Brose N. The cerebellum-specific Munc13 isoform Munc13-3 regulates cerebellar synaptic transmission and motor learning in mice. J. Neurosci. 2001, 21:10-17.
12. Balthazart J., Ball G.F. Is brain estradiol a hormone or a neurotransmitter?. Trends Neurosci. 2006, 29:241-249.
13. Bank B., DeWeer A., Kuzirian A.M., Rasmussen H., Alkon D.L. Classical conditioning induces long-term translocation of protein kinase C in rabbit hippocampal CA1 cells. Proc. Natl. Acad. Sci. U.S.A. 1988, 85:1988-1992.
14. Banks W.A. The source of cerebral insulin. Eur. J. Pharmacol. 2004, 490:5-12.
15. Barsegyan A., Mackenzie S.M., Kurose B.D., McGaugh J.L., Roozendaal B. Glucocorticoids in the prefrontal cortex enhance memory consolidation and impair working memory by a common neural mechanism. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:16655-16660.
16. Basu A., Sivaprasad U. Protein kinase C epsilon makes the life and death decision. Cell Signal 2007, 19:1633-1642.
17. Basu J., Betz A., Brose N., Rosenmund C. Munc13-1 C1 domain activation lowers the energy barrier for synaptic vesicle fusion. J. Neurosci. 2007, 27:1200-1210.
18. Bhullar K.S., Rupasinghe H.P. Polyphenols: multipotent therapeutic agents in neurodegenerative diseases. Oxid. Med. Cell. Longev 2013, Article 891748, 18 pages.
19. Blumberg P.M., Kedei N., Lewin N.E., Yang D., Czifra G., Pu Y., et al. Wealth of opportunity - the C1 domain as a target for drug development. Curr. Drug Targets 2008, 9:641-652.
20. Bluwstein A., Kumar N., Léger K., Traenkle J., Oostrum J., Rehrauer H., et al. PKC signaling prevents irradiation-induced apoptosis of primary human fibroblasts. Cell Death Dis. 2013, 4:e498.
21. Bourne J., Harris K.M. Do thin spines learn to be mushroom spines that remember?. Curr. Opin. Neurobiol. 2007, 17:381-386.
22. Buttery P., Beg A.A., Chih B., Broder A., Mason C.A., Scheiffele P. The diacylglycerol-binding protein alpha1-chimaerin regulates dendritic morphology. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:1924-1929.
23. Calabrese B., Halpain S. Essential role for the PKC target MARCKS in maintaining dendritic spine morphology. Neuron 2005, 48:77-90.
24. Calabrese F., Guidotti G., Racagni G., Riva M.A. Reduced neuroplasticity in aged rats: a role for the neurotrophin brain-derived neurotrophic factor. Neurobiol. Aging 2013, 34:2768-2776.
25. Campbell J.N., Register D., Churn S.B. Traumatic brain injury causes an FK506-sensitive loss and an overgrowth of dendritic spines in rat forebrain. J. Neurotrauma 2012, 29:201-317.
26. Cavallucci V., Berretta N., Nobili A., Nisticò R., Mercuri N.B., D'Amelio M. Calcineurin inhibition rescues early synaptic plasticity deficits in a mouse model of Alzheimer's disease. Neuromolecular Med. 2013, 15:541-548.
27. Cerf E., Gustot A., Goormaghtigh E., Ruysschaert J.M., Raussens V. High ability of apolipoprotein E4 to stabilize amyloidβ peptide oligomers, the pathological entities responsible for Alzheimer's disease. FASEB J. 2011, 25:1585-1595.
28. Chambon C., Jatzke C., Wegener N., Gravius A., Danysz W. Using cholinergic M1 receptor positive allosteric modulators to improve memory via enhancement of brain cholinergic communication. Eur. J. Pharmacol. 2012, 697:73-80.
29. Chamelian L., Reis M., Feinstein A. Six-month recovery from mild to moderate traumatic brain injury: the role of APOEε4 allele. Brain 2004, 127:2621-2628.
30. Chapman J., Vinokurov S., Achiron A., Karussis D.M., Mitosek-Szewczyk K., Birnbaum M., et al. APOE genotype is a major predictor of long-term progression of disability in MS. Neurology 2001, 56:312-316.
31. Chen Y., Lomnitski L., Michaelson D.M., Shohami E. Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury. Neuroscience 1997, 80:1255-1262.
32. Christopherson K.S., Ullian E.M., Stokes C.C., Mullowney C.E., Hell J.W., Agah A., et al. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 2005, 120:421-433.
33. Conesa-Zamora P., Lopez-Andreo M.J., Gómez-Fernández J.C., Corbalán-García S. Identification of the phosphatidylserine binding site in the C2 domain that is important for PKC α activation and in vivo cell localization. Biochemistry 2001, 40:13898-13905.
34. Connor B., Young D., Yan Q., Faull R.L., Synek B., Dragunow M. Brain-derived neurotrophic factor is reduced in Alzheimer's disease. Brain Res. Mol. Brain Res. 1997, 49:71-81.
35. Corbalán-Garcia S., Sánchez-Carrillo S., García-García J., Gómez-Fernández J.C. Characterization of the membrane binding mode of the C2 domain of PKCε. Biochemistry 2003, 42:11661-11668.
36. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261:921-923.
37. Dalva M.B., Takasu M.A., Lin M.Z., Shamah S.M., Hu L., Gale N.W., Greenberg M.E. EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. Cell 2000, 103:945-956.
38. Datta R., Kojima H., Yoshida K., Kufe D.J. Caspase-3-mediated cleavage of protein kinase C theta in induction of apoptosis. J. Biol. Chem. 1997, 272:20317-20320.
39. Deane R., Wu Z., Sagare A., Davis J., Du Yan S., Hamm K., et al. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Aβ isoforms. Neuron 2004, 43:333-344.
40. DeChristopher B.A., Fan A.C., Felsher D.W., Wender P.A. "Picolog," a synthetically-available bryostatin analog, inhibits growth of MYC-induced lymphoma in vivo. Oncotarget 2012, 3:58-66.
41. Della F.P., Abelaira H.M., Réus G.Z., Ribeiro K.F., Antunes A.R., Scaini G., et al. Tianeptine treatment induces antidepressive-like effects and alters BDNF and energy metabolism in the brain of rats. Behav. Brain Res. 2012, 233:526-535.
42. Derakhshan F., Toth C. Insulin and the brain. Curr. Diabetes Rev. 2013, 9:102-116.
43. Derosa G., Maffioli P. Peroxisome proliferator-activated receptorγ (PPARγ) agonists on glycemic control, lipid profile and cardiovascular risk. Curr. Mol. Pharmacol. 2012, 5:272-281.
44. Ding L., Wang H., Lang W., Xiao L. Protein kinase C-epsilon promotes survival of lung cancer cells by suppressing apoptosis through dysregulation of the mitochondrial caspase pathway. J. Biol. Chem. 2002, 277:35305-35313.
45. Duman R.S., Aghajanian G.K. Synaptic dysfunction in depression: potential therapeutic targets. Science 2012, 338:68-72.
46. Eagle A.L., Fitzpatrick C.J., Perrine S.A. Single prolonged stress impairs social and object novelty recognition in rats. Behav. Brain Res. 2013, 256:591-597.
47. Etcheberrigaray R., Matzel L.D., Lederhendler I.I., Alkon D.L. Classical conditioning and protein kinase C activation regulate the same single potassium channel in Hermissenda crassicornis photoreceptors. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:7184-7188.
48. Evans S., Gray M.A., Dowell N.G., Tabet N., Tofts P.S., King S.L., Rusted J.M. APOE E4 carriers show prospective memory enhancement under nicotine, and evidence for specialisation within medial BA10. Neuropsychopharmacology 2013, 38:655-663.
49. Fazekas F., Strasser-Fuchs S., Kollegger H., Berger T., Kristoferitsch W., Schmidt H., et al. Apolipoprotein E ε4 is associated with rapid progression of multiple sclerosis. Neurology 2001, 57:853-857.
50. Fester L., Zhou L., Butow A., Huber C., von Lossow R., Prange-Kiel J., et al. Cholesterol-promoted synaptogenesis requires the conversion of cholesterol to estradiol in the hippocampus. Hippocampus 2009, 19:692-705.
51. Frick K.M. Epigenetics, estradiol, and hippocampal memory consolidation. J. Neuroendocrinol. 2013, 25:1151-1162.
52. Frye C.A., Rhodes M.E. Enhancing effects of estrogen on inhibitory avoidance performance may be in part independent of intracellular estrogen receptors in the hippocampus. Brain Res. 2002, 956:285-293.
53. Fukuhara K., Ishikawa K., Yasuda S., Kishishita Y., Kim H.K., Kakeda T., et al. Intracerebroventricular 4-methylcatechol (4-MC) ameliorates chronic pain associated with depression-like behavior via induction of brain-derived neurotrophic factor (BDNF). Cell Mol. Neurobiol. 2012, 32:971-977.
54. Fukumitsu H., Sometani A., Ohmiya M., Nitta A., Nomoto H., Furukawa Y., Furukawa S. Induction of a physiologically active brain-derived neurotrophic factor in the infant rat brain by peripheral administration of 4-methylcatechol. Neurosci. Lett. 1999, 274:115-118.
55. Gao X., Deng P., Xu Z.C., Chen J. Moderate traumatic brain injury causes acute dendritic and synaptic degeneration in the hippocampal dentate gyrus. PLoS One 2011, 6:e24566.
56. Ghasemi R., Haeri A., Dargahi L., Mohamed Z., Ahmadiani A. Insulin in the brain: sources, localization and functions. Mol. Neurobiol. 2013, 47:145-171.
57. Gillespie S., Zhang X.D., Hersey P. Variable expression of protein kinase C epsilon in human melanoma cells regulates sensitivity to TRAIL-induced apoptosis. Mol. Cancer Ther. 2005, 4:668-676.
58. Gipson C.D., Reissner K.J., Kupchik Y.M., Smith A.C., Stankeviciute N., Hensley-Simon M.E., Kalivas P.W. Reinstatement of nicotine seeking is mediated by glutamatergic plasticity. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:9124-9129.
59. Goritz C., Mauch D.H., Pfrieger F.W. Multiple mechanisms mediate cholesterol-induced synaptogenesis in a CNS neuron. Mol. Cell. Neurosci. 2005, 29:190-201.
60. Goutan E., Martí E., Ferrer I. BDNF, and full length and truncated TrkB expression in the hippocampus of the rat following kainic acid excitotoxic damage. Evidence of complex time-dependent and cell-specific responses. Brain Res. Mol. Brain Res. 1998, 59:154-164.
61. Govindarajan A., Israely I., Huang S.Y., Tonegawa S. The dendritic branch is the preferred integrative unit for protein synthesis-dependent LTP. Neuron 2011, 69:132-146.
62. Gräff J., Tsai L.H. The potential of HDAC inhibitors as cognitive enhancers. Annu. Rev. Pharmacol. Toxicol. 2013, 53:311-330.
63. Grundy P.L., Patel N., Harbuz M.S., Lightman S.L., Sharples P.M. Glucocorticoids modulate BDNF mRNA expression in the rat hippocampus after traumatic brain injury. Neuroreport 2000, 11:3381-3384.
64. Hajszan T., Dow A., Warner-Schmidt J.L., Szigeti-Buck K., Sallam N.L., Parducz A., et al. Remodeling of hippocampal spine synapses in the rat learned helplessness model of depression. Biol. Psychiatry 2009, 65:392-400.
65. Hall B.J., Ghosh A. Regulation of AMPA receptor recruitment at developing synapses. Trends Neurosci. 2008, 31:82-89.
66. Hama H., Hara C., Yamaguchi K., Miyawaki A. PKC signaling mediates global enhancement of excitatory synaptogenesis in neurons triggered by local contact with astrocytes. Neuron 2004, 41:405-415.
67. He Q., Dent E.W., Meiri K.F. Modulation of actin filament behavior by GAP-43 (neuromodulin) is dependent on the phosphorylation status of serine 41, the protein kinase C site. J. Neurosci. 1997, 17:3515-3524.
68. Hell J.W. CaMKII: claiming center stage in postsynaptic function and organization. Neuron 2014, 81:249-265.
69. Hashimoto T., Serrano-Pozo A., Hori Y., Adams K.W., Takeda S., Banerji A.O., et al. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid beta peptide. J. Neurosci. 2012, 32:15181-15192.
70. Hauser P.S., Narayanaswami V., Ryan R.O. Apolipoprotein E: from lipid transport to neurobiology. Prog. Lipid Res. 2011, 50:62-74.
71. Holtzman D.M., Hyman B.T. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide. J. Neurosci. 2012, 32:15181-15192.
72. Hawk J.D., Bookout A.L., Poplawski S.G., Bridi M., Rao A.J., Sulewski M.E., et al. NR4A nuclear receptors support memory enhancement by histone deacetylase inhibitors. J. Clin. Invest. 2012, 122:3593-3602.
73. Henckens M., Hermans E.J., Pu Z., Joels M., Fernandez G. Stressed memories: how acute stress affects memory formation in humans. J. Neurosci. 2009, 29:10111-10119.
74. Henley J.M., Barker E.A., Glebov O.O. Routes, destinations and delays: recent advances in AMPA receptor trafficking. Trends Neurosci. 2011, 34:258-268.
75. Hodge C.W., Mehmert K.K., Kelley S.P., McMahon T., Haywood A., Olive M.F., et al. Supersensitivity to allosteric GABA(A) receptor modulators and alcohol in mice lacking PKCε. Nat. Neurosci. 1999, 2:997-1002.
76. Hongpaisan J., Alkon D.L. A structural basis for enhancement of long-term associative memory in single dendritic spines regulated by PKC. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:19571-19576.
77. Hongpaisan J., Sun M.K., Alkon D.L. PKC ε activation prevents synaptic loss, Aβ elevation, and cognitive deficits in Alzheimer's disease transgenic mice. J. Neurosci. 2011, 31:630-643.
78. Hongpaisan J., Xu C., Sen A., Nelson T.J., Alkon D.L. PKC activation during training restores mushroom spine synapses and memory in the aged rat. Neurobiol. Dis. 2013, 55:44-62.
79. Hotulainen P., Hoogenraad C.C. Actin in dendritic spines: connecting dynamics to function. J. Cell Biol. 2010, 189:619-629.
80. Hruska M., Dalva M.B. Ephrin regulation of synapse formation, function and plasticity. Mol. Cell. Neurosci. 2012, 50:35-44.
81. Jellinger K.A., Paulus W., Wrocklage C., Litvan I. Traumatic brain injury as a risk factor for Alzheimer disease. Comparison of two retrospective autopsy cohorts with evaluation of ApoE genotype. BMC Neurol. 2001, 1:3.
82. Ji Y., Gong Y., Gan W., Beach T., Holtzman D.M., Wisniewski T. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients. Neuroscience 2003, 122:305-315.
83. Jiang C., Schuman E.M. Regulation and function of local protein synthesis in neuronal dendrites. Trends Biochem. Sci. 2002, 27:506-513.
84. Johnson V.E., Stewart W., Smith D.H. Widespread Tau and amyloid-beta pathology many years after a single traumatic brain injury in humans. Brain Pathol. 2011, 22:142-149.
85. Kaechi K., Furukawa Y., Ikegami R., Nakamura N., Omae F., Hashimoto Y., et al. Pharmacological induction of physiologically active nerve growth factor in rat peripheral nervous system. J. Pharmacol. Exp. Ther. 1993, 264:321-326.
86. Kaechi K., Ikegami R., Nakamura N., Nakajima M., Furukawa Y., Furukawa S. 4-Methylcatechol, an inducer of NGF synthesis, enhances peripheral nerve regeneration across nerve gaps. J. Pharmacol. Exp. Ther. 1995, 272:1300-1304.
87. Kasai H., Fukuda M., Watanabe S., Hayashi-Takagi A., Noguchi J. Structural dynamics of dendritic spines in memory and cognition. Trends Neurosci. 2010, 33:121-129.
88. Keshamouni V.G., Mattingly R.R., Reddy K.B. Mechanism of 17β-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 and PKCδ. J. Biol. Chem. 2002, 277:22558-22565.
89. Kessels H.W., Malinow R. Synaptic AMPA receptor plasticity and behavior. Neuron 2009, 61:340-350.
90. Kim C.Y., Koo Y.D., Jin J.B., Moon B.C., Kang C.H., Kim S.T., et al. Rice C2-domain proteins are induced and translocated to the plasma membrane in response to a fungal elicitor. Biochemistry 2003, 42:11625-11633.
91. Kiraly D.D., Stone K.L., Colangelo C.M., Abbott T., Wang Y., Mains R.E., Eipper B.A. Identification of kalirin-7 as a potential post-synaptic density signaling hub. J. Proteome Res. 2011, 10:2828-2841.
92. Kitagawa K. CREB and cAMP response element-mediated gene expression in the ischemic brain. FEBS J. 2007, 274:3210-3217.
93. Koleske A.J. Molecular mechanisms of dendrite stability. Nat. Rev. Neurosci. 2013, 14:536-550.
94. Körner C., Keklikoglou I., Bender C., Wörner A., Münstermann E., Wiemann S. MicroRNA-31 sensitizes human breast cells to apoptosis by direct targeting of protein kinase C epsilon (PKCε). J. Biol. Chem. 2013, 288:8750-8761.
95. Kramár E.A., Chen L.Y., Brandon N.J., Rex C.S., Liu F., Gall C.M., Lynch G. Cytoskeletal changes underlie estrogen's acute effects on synaptic transmission and plasticity. J. Neurosci. 2009, 29:12982-12993.
96. Kretz O., Fester L., Wehrenberg U., Zhou L., Brauckmann S., Zhao S., et al. Hippocampal synapses depend on hippocampal estrogen synthesis. J. Neurosci. 2004, 24:5913-5921.
97. Lanterna L.A., Biroli F. Significance of apolipoprotein E in subarachnoid hemorrhage: neuronal injury, repair, and therapeutic perspectives-a review. J. Stroke Cerebrovasc. Dis. 2009, 18:116-123.
98. Larroque-Cardoso P., Swiader A., Ingueneau C., Nègre-Salvayre A., Elbaz M., Reyland M.E., et al. Role of protein kinase C δ in ER stress and apoptosis induced by oxidized LDL in human vascular smooth muscle cells. Cell Death Dis. 2013, 4:e520.
99. Leal G., Comprido D., Duarte C.B. BDNF-induced local protein synthesis and synaptic plasticity. Neuropharmacology 2014, 76(Pt C):639-656.
100. Lee B., Sur B., Shim I., Lee H., Hahm D.H. Baicalin improves chronic corticosterone-induced learning and memory deficits via the enhancement of impaired hippocampal brain-derived neurotrophic factor and cAMP response element-binding protein expression in the rat. J. Nat. Med. 2013, 68:132-143.
101. Lerner-Natoli M., Ladrech S., Renard N., Puel J.L., Eybalin M., Pujol R. Protein kinase C may be involved in synaptic repair of auditory neuron dendrites after AMPA injury in the cochlea. Brain Res. 1997, 749:109-119.
102. Lesscher H.M., Wallace M.J., Zeng L., Wang V., Deitchman J.K., McMahon T., et al. Amygdala protein kinase C epsilon controls alcohol consumption. Genes Brain Behav. 2009, 8:493-499.
103. Léveillé F., Papadia S., Fricker M., Bell K.F., Soriano F.X., Martel M.A., et al. Suppression of the intrinsic apoptosis pathway by synaptic activity. J. Neurosci. 2010, 30:2623-2635.
104. Li C., Brake W.G., Romeo R.D., Dunlop J.C., Gordon M., Buzescu R., et al. Estrogen alters hippocampal dendritic spine shape and enhances synaptic protein immunoreactivity and spatial memory in female mice. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:2185-2190.
105. Lichtman S.W., Seliger G., Tycko B., Marder K. Apolipoprotein E and functional recovery from brain injury following post acute rehabilitation. Neurology 2000, 55:1536-1539.
106. Lieberman J.A., Dunbar G., Segreti A.C., Girgis R.R., Seoane F., Beaver J.S., et al. A randomized exploratory trial of an α-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia. Neuropsychopharmacology 2013, 38:968-975.
107. Lim B.K., Matsuda N., Poo M.M. Ephrin-B reverse signaling promotes structural and functional synaptic maturation in vivo. Nat. Neurosci. 2008, 11:160-169.
108. Lim C.S., Alkon D.L. Protein kinase C stimulates HuD-mediated mRNA stability and protein expression of neurotrophic factors and enhances dendritic maturation of hippocampal neurons in culture. Hippocampus 2012, 22:2303-2319.
109. Liu F., Day M., Muñiz L.C., Bitran D., Arias R., Revilla-Sanchez R., et al. Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory. Nat. Neurosci. 2008, 11:334-343.
110. Liu X., Betzenhauser M.J., Reiken S., Meli A.C., Xie W., Chen B.X., et al. Role of leaky neuronal ryanodine receptors in stress-induced cognitive dysfunction. Cell 2012, 150:1055-1067.
111. Lopes J.P., Tarozzo G., Reggiani A., Piomelli D., Cavalli A. Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity. Brain Behav. 2013, 3:67-74.
112. Lorenzo P.S., Beheshti M., Pettit G.R., Stone J.C., Blumberg P.M. The guanine nucleotide exchange factor RasGRP is a high-affinity target for diacylglycerol and phorbol esters. Mol. Pharmacol. 2000, 57:840-846.
113. Lu B., Nagappan G., Guan X., Nathan P.J., Wren P. BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nat. Rev. Neurosci. 2013, 14:401-416.
114. Lu Z., Hornia A., Jiang Y.W., Zang Q., Ohno S., Foster D.A. Tumor promotion by depleting cells of protein kinase C delta. Mol. Cell Biol. 1997, 17:3418-3428.
115. Maher P., Akaishi T., Schubert D., Abe K. A pyrazole derivative of curcumin enhances memory. Neurobiol. Aging 2010, 31:706-709.
116. Mahley R.W., Huang Y., Weisgraber K.H. Detrimental effects of apolipoprotein E4: potential therapeutic targets in Alzheimer's disease. Curr. Alzheimer Res. 2007, 4:537-540.
117. Mahley R.W., Huang Y. Apolipoprotein E sets the stage: response to injury triggers neuropathology. Neuron 2012, 76:871-885.
118. Marland J.R., Pan D., Buttery P.C. Rac GTPase-activating protein (Rac GAP) α1-Chimaerin undergoes proteasomal degradation and is stabilized by diacylglycerol signaling in neurons. J. Biol. Chem. 2011, 286:199-207.
119. Martens S. Role of C2 domain proteins during synaptic vesicle exocytosis. Biochem. Soc. Trans. 2010, 38(Pt 1):213-216.
120. Martijena I.D., Molina V.A. The influence of stress on fear memory processes. Braz. J. Med. Biol. Res. 2012, 45:308-313.
121. Masi G., Brovedani P. The hippocampus, neurotrophic factors and depression: possible implications for the pharmacology of depression. CNS Drugs 2011, 25:913-931.
122. Matsuzaki M., Honkura N., Ellis-Davies G.C., Kasai H. Structural basis of long-term potentiation in single dendritic spines. Nature 2004, 429:761-766.
123. Mauch D.H., Nagler K., Schumacher S., Goritz C., Muller E., Otto A., Pfreiger F. CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001, 294:1354-1357.
124. Mayer G., Nitsch R., Hoyer S. Effects of changes in peripheral and cerebral glucose metabolism on locomotor activity, learning and memory in adult male rats. Brain Res. 1990, 532:95-100.
125. McCarron M.O., Delong D., Alberts M.J. APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology 1999, 53:1308-1311.
126. McGaugh J.L., Roozendaal B. Role of adrenal stress hormones in forming lasting memories in the brain. Curr. Opin. Neurobiol. 2002, 12:205-210.
127. Mereu M., Bonci A., Newman A.H., Tanda G. The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders. Psychopharmacology (Berl) 2013, 229:415-434.
128. Miller B.W., Willett K.C., Desilets A.R. Rosiglitazone and pioglitazone for the treatment of Alzheimer's disease. Ann. Pharmacother. 2011, 45:1416-1424.
129. Mizuno K., Noda K., Araki T., Imaoka T., Kobayashi Y., Akita Y., et al. The proteolytic cleavage of protein kinase C isotypes, which generates kinase and regulatory fragments, correlates with Fas-mediated and 12-O-tetradecanoyl-phorbol-13-acetate-induced apoptosis. Eur. J. Biochem. 1997, 250:7-18.
130. Murai K.K., Nguyen L.N., Irie F., Yamaguchi Y., Pasquale E.B. Control of hippocampal dendritic spine morphology through ephrin-A3/EphA4 signaling. Nat. Neurosci. 2003, 6:153-160.
131. Murai K.K., Pasquale E.B. Eph receptors and ephrins in neuron-astrocyte communication at synapses. Glia 2011, 59:1567-1578.
132. Murphy D.D., Cole N.B., Segal M. Brain-derived neurotrophic factor mediates estradiol-induced dendritic spine formation in hippocampal neurons. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:11412-11417.
133. Murray K.D., Gall C.M., Jones E.G., Isackson P.J. Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease. Neuroscience 1994, 60:37-48.
134. Neary J.T., Crow T., Alkon D.L. Change in a specific phosphoprotein band following associative learning in Hermissenda. Nature 1981, 293:658-660.
135. Nelson T.J., Collin C., Alkon D.L. Isolation of a G protein that is modified by learning and reduces potassium currents in Hermissenda. Science 1990, 247:1479-1483.
136. Nelson T.J., Alkon D.L. Neuroprotective versus tumorigenic protein kinase C activators. Trends Biochem. Sci. 2009, 34:136-145.
137. Newey S.E., Velamoor V., Govek E.E., Van Aelst L. Rho GTPases, dendritic structure, and mental retardation. J. Neurobiol. 2005, 64:58-74.
138. Newton P.M., Kim J.A., McGeehan A.J., Paredes J.P., Chu K., Wallace M.J., et al. Increased response to morphine in mice lacking protein kinase C epsilon. Genes Brain Behav. 2007, 6:329-338.
139. Nitta A., Ito M., Fukumitsu H., Ohmiya M., Ito H., Sometani A., et al. 4-methylcatechol increases brain-derived neurotrophic factor content and mRNA expression in cultured brain cells and in rat brain in vivo. J. Pharmacol. Exp. Ther. 1999, 291:1276-1283.
140. Okhrimenko H., Lu W., Xiang C., Hamburger N., Kazimirsky G., Brodie C. Protein kinase C-epsilon regulates the apoptosis and survival of glioma cells. Cancer Res. 2005, 65:7301-7309.
141. Olds J.L., Anderson M.L., McPhie D.L., Staten L.D., Alkon D.L. Imaging of memory-specific changes in the distribution of protein kinase C in the hippocampus. Science 1989, 245:866-869.
142. Olive M.F., Newton P.M. Protein kinase C isozymes as regulators of sensitivity to and self-administration of drugs of abuse-studies with genetically modified mice. Behav. Pharmacol. 2010, 21:493-499.
143. Olsson A., Csajbok L., Ost M., Höglund K., Nylén K., Rosengren L., et al. Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury. J. Neurol. 2004, 251:870-876.
144. Oulès B., Del Prete D., Greco B., Zhang X., Lauritzen I., Sevalle J., et al. Ryanodine receptor blockade reduces amyloidβ load and memory impairments in Tg2576 mouse model of Alzheimer disease. J. Neurosci. 2012, 32:11820-11834.
145. Pa J., Berry A.S., Compagnone M., Boccanfuso J., Greenhouse I., Rubens M.T., et al. Cholinergic enhancement of functional networks in older adults with mild cognitive impairment. Ann. Neurol. 2013, 73:762-773.
146. Pardridge W.M., Wu D., Sakane T. Combined use of carboxyl-directed protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration. Pharmacol. Res. 1998, 15:576-582.
147. Pasinetti G.M. Novel role of red wine-derived polyphenols in the prevention of Alzheimer's disease dementia and brain pathology: experimental approaches and clinical implications. Planta Med. 2012, 78:1614-1619.
148. Penzes P., Jones K.A. Dendritic spine dynamics-a key role for kalirin-7. Trends Neurosci. 2008, 31:419-427.
149. Perez-Cruz C., Nolte M.W., van Gaalen M.M., Rustay N.R., Termont A., Tanghe A., et al. Reduced spine density in specific regions of CA1 pyramidal neurons in two transgenic mouse models of Alzheimer's disease. J. Neurosci. 2011, 31:3926-3934.
150. Phillips H.S., Hains H.S., Armanini M., Laramee G.R., Johnson S.A., Winslow J.W. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 1991, 7:695-702.
151. Piechota M., Korostynski M., Solecki W., Gieryk A., Slezak M., Bilecki W., et al. The dissection of transcriptional modules regulated by various drugs of abuse in the mouse striatum. Genome Biol. 2010, 11:R48.
152. Pitchers K.K., Vialou V., Nestler E.J., Laviolette S.R., Lehman M.N., Coolen L.M. Natural and drug rewards act on common neural plasticity mechanisms with δFosB as a key mediator. J. Neurosci. 2013, 33:3434-3442.
153. Pollak D.D., Rey C.E., Monje F.J. Rodent models in depression research: classical strategies and new directions. Ann. Med. 2010, 42:252-264.
154. Pryce C.R., Azzinnari D., Spinelli S., Seifritz E., Tegethoff M., Meinlschmidt G. Helplessness: a systematic translational review of theory and evidence for its relevance to understanding and treating depression. Pharmacol. Ther. 2011, 132:242-267.
155. Pulipparacharuvil S., Renthal W., Hale C.F., Taniguchi M., Xiao G., Kumar A., et al. Cocaine regulates MEF2 to control synaptic and behavioral plasticity. Neuron 2008, 59:621-633.
156. Ramírez-Rodríguez G., Ocaña-Fernández M.A., Vega-Rivera N.M., Torres-Pérez O.M., Gómez-Sánchez A., Estrada-Camarena E., Ortiz-López L. Environmental enrichment induces neuroplastic changes in middle age female BalbC mice and increases the hippocampal levels of BDNF, p-Akt and p-MAPK1/2. Neuroscience 2014, 260:158-170.
157. Raval A.P., Borges-Garcia R., Javier Moreno W., Perez-Pinzon M.A., Bramlett H. Periodic 17β-estradiol pretreatment protects rat brain from cerebral ischemic damage via estrogen receptorβ. PLoS One 2013, 8:e60716.
158. Recio-Pinto E., Lang F.F., Ishii D.N. Insulin and insulin-like growth factor II permit nerve growth factor binding and the neurite formation response in cultured human neuroblastoma cells. Proc. Natl. Acad. Sci. U.S.A. 1984, 81:2562-2566.
159. Reger M., Watson G., Frey I., Baker L., Cholerton B., Keeling M., et al. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol. Aging 2006, 27:451-458.
160. Reger M.A., Watson G.S., Green P.S., Baker L.D., Cholerton B., Fishel M.A., et al. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J. Alzheimers Dis. 2008, 13:323-331.
161. Rhee J.S., Betz A., Pyott S., Reim K., Varoqueaux F., Augustin I., et al. Beta phorbol ester- and diacylglycerol-induced augmentation of transmitter release is mediated by Munc13s and not by PKCs. Cell 2002, 108:121-133.
162. Ridley A.J. Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol. 2006, 16:522-529.
163. Robleto K., Poulos A.M., Thompson R.F. Brain mechanisms of extinction of the classically conditioned eyeblink response. Learn. Mem. 2004, 11:517-524.
164. Romero A.M., Renau-Piqueras J., Pilar Marin M., Timoneda J., Berciano M.T., Lafarga M., Esteban-Pretel G. Chronic alcohol alters dendritic spine development in neurons in primary culture. Neurotox. Res. 2013, 24:532-548.
165. Rossman K.L., Der C.J., Sondek J. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat. Rev. Mol. Cell Biol. 2005, 6:167-180.
166. Rozkalne A., Hyman B.T., Spires-Jones T.L. Calcineurin inhibition with FK506 ameliorates dendritic spine density deficits in plaque-bearing Alzheimer model mice. Neurobiol. Dis. 2011, 41:650-654.
167. Sandstrom N.J., Williams C.L. Memory retention is modulated by acute estradiol and progesterone replacement. Behav. Neurosci. 2001, 115:384-393.
168. Schaffer S., Asseburg H., Kuntz S., Muller W.E., Eckert G.P. Effects of polyphenols on brain ageing and Alzheimer's disease: focus on mitochondria. Mol. Neurobiol. 2012, 46:161-178.
169. Schmechel D.E., Saunders A.M., Strittmatter W.J., Crain B.J., Hulette C.M., Joo S.H., et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:9649-9653.
170. Schoenfeld T.J., Gould E. Stress, stress hormones, and adult neurogenesis. Exp. Neurol. 2012, 233:12-21.
171. Schwabe L., Joëls M., Roozendaal B., Wolf O.T., Oitzl M.S. Stress effects on memory: an update and integration. Neurosci. Biobehav. Rev. 2012, 36:1740-1749.
172. Scott R., Bourtchuladze R., Gossweiler S., Dubnau J., Tully T. CREB and the discovery of cognitive enhancers. J. Mol. Neurosci. 2002, 19:171-177.
173. Sen A., Alkon D.L., Nelson T.J. Apolipoprotein E3 (ApoE3) but not ApoE4 protects against synaptic loss through increased expression of protein kinase C epsilon. J. Biol. Chem. 2012, 287:15947-15958.
174. Shipman S.L., Nicoll R.A. Dimerization of postsynaptic neuroligin drives synaptic assembly via transsynaptic clustering of neurexin. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:19432-19437.
175. Shirai Y., Kouzuki T., Kakefuda K., Moriguchi S., Oyagi A., Horie K., et al. Essential role of neuron-enriched diacylglycerol kinase (DGK), DGKβ in neurite spine formation, contributing to cognitive function. PLoS One 2010, 5:e11602.
176. Sivaprasad U., Shankar E., Basu A. Downregulation of Bid is associated with PKCε-mediated TRAIL resistance. Cell Death Differ. 2007, 14:851-857.
177. Smith L., Chen L., Reyland M.E., DeVries T.A., Talanian R.V., Omura S., Smith J.B. Activation of atypical protein kinase C zeta by caspase processing and degradation by the ubiquitin-proteasome system. J. Biol. Chem. 2000, 275:40620-40627.
178. Sometani A., Nomoto H., Nitta A., Furukawa Y., Furukawa S. 4-Methylcatechol stimulates phosphorylation of Trk family neurotrophin receptors and MAP kinases in cultured rat cortical neurons. J. Neurosci. Res. 2002, 70:335-339.
179. Sosa M.S., Lewin N.E., Choi S.H., Blumberg P.M., Kazanietz M.G. Biochemical characterization of hyperactive β2-chimaerin mutants revealed an enhanced exposure of C1 and Rac-GAP domains. Biochemistry 2009, 48:8171-8178.
180. Stafford R.L., Ear J., Knight M.J., Bowie J.U. The molecular basis of the Caskin1 and Mint1 interaction with CASK. J. Mol. Biol. 2011, 412:3-13.
181. Steinberg S.F. Structural basis of protein kinase C isoform function. Physiol. Rev. 2008, 88:1341-1378.
182. Südhof T.C., Rizo J. Synaptotagmins: C2-domain proteins that regulate membrane traffic. Neuron 1996, 17:379-388.
183. Sun M.K., Alkon D.L. Dual effects of bryostatin-1 on spatial memory and depression. Eur. J. Pharmacol. 2005, 512:43-51.
184. Sun M.K., Alkon D.L. Effects of 4-methylcatechol on spatial memory and depression. Neuroreport 2008, 19:355-359.
185. Sun M.K., Hongpaisan J., Nelson T.J., Alkon D.L. Poststroke neuronal rescue and synaptogenesis mediated in vivo by protein kinase C in adult brains. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:13620-13625.
186. Sun M.K., Hongpaisan J., Alkon D.L. Postischemic PKC activation rescues retrograde and anterograde long-term memory. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:14676-14680.
187. Tabuchi K., Biederer T., Butz S., Sudhof T.C. CASK participates in alternative tripartite complexes in which Mint 1 competes for binding with caskin 1, a novel CASK-binding protein. J. Neurosci. 2002, 22:4264-4273.
188. Tanaka M., Sawada M., Miura M., Marunouchi T. Insulin-like growth factor-I analogue prevents apoptosis mediated through an interleukin-1 beta converting enzyme (caspase-1)-like protease of cerebellar external granular layer neurons: developmental stage-specific mechanisms of neuronal cell death. Neuroscience 1998, 84:89-100.
189. Teasdale G.M., Nicoll J.A.R., Murray G., Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 1997, 350:1069-1071.
190. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 1991, 30:572-580.
191. Timmermans W., Xiong H., Hoogenraad C.C., Krugers H.J. Stress and excitatory synapses: from health to disease. Neuroscience 2013, 248:626-636.
192. Tolias K.F., Bikoff J.B., Burette A., Paradis S., Harrar D., Tavazoie S., et al. The Rac1-GEF Tiam1 couples the NMDA receptor to the activity-dependent development of dendritic arbors and spines. Neuron 2005, 45:525-538.
193. Tolias K.F., Bikoff J.B., Kane C.G., Tolias C.S., Hu L., Greenberg M.E. The Rac1 guanine nucleotide exchange factor Tiam1 mediates EphB receptor-dependent dendritic spine development. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:7265-7270.
194. Tolias K.F., Duman J.G., Um K. Control of synapse development and plasticity by Rho GTPase regulatory proteins. Prog. Neurobiol. 2011, 94:133-148.
195. Valladolid-Acebes I., Fole A., Martín M., Morales L., Victoria Cano M., Ruiz-Gayo M., Olmo N.D. Spatial memory impairment and changes in hippocampal morphology are triggered by high-fat diets in adolescent mice. Is there a role of leptin?. Neurobiol. Learn. Mem. 2013, 106C:18-25.
196. Van de Ven T.J., VanDongen H.M., VanDongen A.M. The nonkinase phorbol ester receptor α1-chimerin binds the NMDA receptor NR2A subunit and regulates dendritic spine density. J. Neurosci. 2005, 25:9488-9496.
197. Van Den Heuvel C., Blumbergs P.C., Finnie J.W., Manavis J., Jones N.R., Reilly P.L., Pereira R.A. Upregulation of amyloid precursor protein messenger RNA in response to traumatic brain injury: an ovine head impact model. Exp. Neurol. 1999, 159:441-450.
198. Wallace M.J., Newton P.M., McMahon T., Connolly J., Huibers A., Whistler J., Messing R.O. PKCε regulates behavioral sensitivity, binding and tolerance to the CB1 receptor agonist WIN55,212-2. Neuropsychopharmacology 2009, 34:1733-1742.
199. Walton M.R., Dragunow I. Is CREB a key to neuronal survival?. Trends Neurosci. 2000, 23:48-53.
200. Wang T., Yang Y.J., Wu P.F., Wang W., Hu Z.L., Long L.H., et al. Tetrahydroxystilbene glucoside, a plant-derived cognitive enhancer, promotes hippocampal synaptic plasticity. Eur. J. Pharmacol. 2011, 650:206-214.
201. Wang X.D., Su Y.A., Wagner K.V., Avrabos C., Scharf S.H., Hartmann J., et al. Nectin-3 links CRHR1 signaling to stress-induced memory deficits and spine loss. Nat. Neurosci. 2013, 16:706-713.
202. Wei J., Yuen E.Y., Liu W., Li X., Zhong P., Karatsoreos I.N., et al. Estrogen protects against the detrimental effects of repeated stress on glutamatergic transmission and cognition. Mol. Psychiatry 2013, 19:588-598.
203. Wojcik S.M., Brose N. Regulation of membrane fusion in synaptic excitation secretion coupling: speed and accuracy matter. Neuron 2007, 55:11-24.
204. Woolley C.S., McEwen B.S. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J. Neurosci. 1992, 12:2549-2554.
205. Wu G., Malinow R., Cline H.T. Maturation of a central glutamatergic synapse. Science 1996, 274:972-976.
206. Xia Y., Wang C.Z., Liu J., Anastasio N.C., Johnson K.M. Brain-derived neurotrophic factor prevents phencyclidine-induced apoptosis in developing brain by parallel activation of both the ERK and PI-3K/Akt pathways. Neuropharmacology 2010, 58:330-336.
207. Yamada K., Nabeshima T. Brain-derived neurotrophic factor/TrkB signaling in memory processes. J. Pharmacol. Sci. 2003, 91:267-270.
208. Yan J.Z., Xu Z., Ren S.Q., Hu B., Yao W., Wang S.H., Liu S.Y., Lu W. Protein kinase C promotes N-methyl-d-aspartate (NMDA) receptor trafficking by indirectly triggering calcium/calmodulin-dependent protein kinase II (CaMKII) autophosphorylation. J. Biol. Chem. 2011, 286:25187-25200.
209. Yang C.P., Gilley J.A., Zhang G., Kernie S.G. ApoE is required for maintenance of the dentate gyrus neural progenitor pool. Development 2011, 138:4351-4362.
210. Zeng Y., Liu Y., Wu M., Liu J., Hu Q. Activation of TrkB by 7,8-dihydroxyflavone prevents fear memory defects and facilitates amygdalar synaptic plasticity in aging. J. Alzheimers Dis. 2012, 31:765-778.
211. Zhang H., Etherington L.A., Hafner A.S., Belelli D., Coussen F., Delagrange P., et al. Regulation of AMPA receptor surface trafficking and synaptic plasticity by a cognitive enhancer and antidepressant molecule. Mol. Psychiatry 2013, 18:471-484.
212. Zhang H., Webb D.J., Asmussen H., Niu S., Horwitz A.F. A GIT1/PIX/Rac/PAK signaling module regulates spine morphogenesis and synapse formation through MLC. J. Neurosci. 2005, 25:3379-3388.
213. Zhang Y., Luan Z., Liu A., Hu G. The scaffolding protein CASK mediates the interaction between rabphilin3a and beta-neurexins. FEBS Lett. 2001, 497:99-102.
214. Zhao W., Chen H., Xu H., Moore E., Meiri N., Quon M.J., Alkon D.L. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J. Biol. Chem. 1999, 274:34893-34902.
215. Zhao W., Meiri N., Xu H., Cavallaro S., Quattrone A., Zhang L., Alkon D.L. Spatial learning induced changes in expression of the ryanodine type II receptor in the rat hippocampus. FASEB J. 2000, 14:290-300.
216. Zhou L., Jones E.V., Murai K.K. EphA signaling promotes actin-based dendritic spine remodeling through slingshot phosphatase. J. Biol. Chem. 2012, 287:9346-9359.
217. Zlokovic B.V., Deane R., Sagare A.P., Bell R.D., Winkler E.A. Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism for controlling Alzheimer's amyloid beta-peptide elimination from the brain. J. Neurochem. 2010, 115:1077-1089.
218. Zohar O., Lavy R., Zi X., Nelson T.J., Hongpaisan J., Pick C.G., Alkon D.L. PKC activator therapeutic for mild traumatic brain injury in mice. Neurobiol. Dis. 2011, 41:329-337.